Podcasts about press releases

Today on The Professionally Evil Perspective, Kevin and Nathan discuss the FTC actions on the Drizly breach and the responsibility of CEO's when security fails. Press Release: https://www.ftc.gov/news-events/news/press-releases/2022/10/ftc-takes-action-against-drizly-its-ceo-james-cory-rellas-security-failures-exposed-data-25-million Actual Ruling: https://www.ftc.gov/system/files/ftc_gov/pdf/202-3185-Drizly-Decision-and-Order.pdf Got suggestions, complaints, or feedback? Tell us at podcast@secureideas.com or reach out on Twitter: @sweaney@darth_kevin @secureideas or find us on Mastadon: @secureideas Join our Professionally Evil Slack Team at www.professionallyevil.com Our real jobs pay for our time to do this, so if you have opportunities around penetration testing or risk management, we'd love the chance to work with you!

This podcast is the Second Annual Audio description Project Awards Gala aired at 7:30 PM November 29, 2022. Press Release follows: American Council of the Blind Salutes Audio Description Award Winners Nov. 30 2022 — The American Council of the Blind (ACB) would like to thank all those who participated in the 2022 Audio Description Awards Gala that premiered on November 29th on www.AdAwardsGala.org and Pluto TV. “We are proud to host the second annual Audio Description Awards Gala to recognize excellence in audio described content and celebrate the growing commitment to accessible media for people who are blind and low vision,” said ACB's Executive Director, Eric Bridges. ACB thanks host Thomas Reid and Audio Description Voice Talent Nefertiti Matos Olivares as well as our special guests who lent their talent to the event and support for accessible media for all, including Stevie Wonder, Ewan McGregor, Nesta Cooper, Camryn Manheim, Shayla Brown, and the cast of iCarly! This year's honorees have been carefully selected by a diverse group of leaders from ACB's Audio Description Awards Committee, who have identified recipients as both audio description content leaders and media industry game changers.  Award Winners Outstanding Audio Description Visionary - Larry Goldberg Audio Description Game Changer: Innovation - Microsoft Audio Description Game Changer: Inclusion - Academy of Television Arts and Sciences Audio Description Game Changer: Education - Described and Captioned Media Program Outstanding Achievement: Live Events - Paramount Global Outstanding Achievement: Spanish Media (USA) - Telemundo/Hearst Outstanding Achievement: International Media - AMI Audio Description People's Choice Award - Obi-Wan Kenobi (Disney+/Lucasfilm/Audio Description by Deluxe) ACB President Dan Spoone, added, “And finally, thank you to our sponsors: Silver Star Sponsors — Amazon, Disney, Microsoft, Paramount Global, Warner Bros. Discovery and our Bronze Star Sponsors — Charter Spectrum, Keyword Studios, Fox, as well as the National Association of Broadcasters.” The Audio Description Awards Gala celebrated the inclusivity and accessibility of media by recognizing those in television, streaming and the film industry's achievements in audio description for accessible media for blind and low vision audiences. For more details visit www.AdAwardsGala.org. The American Council of the Blind is a national member-driven organization representing Americans who are blind and visually impaired. For more than 60 years, ACB has become a leader in national, state, local, and even international advocacy efforts. With 68 affiliates, ACB strives to increase independence, security, equality of opportunity, and to improve the quality of life for all people who are blind and visually impaired. For more information, visit www.acb.org.  You can help!Make a secure online donation today       Find out more at https://acb-events.pinecast.co

Jadi, Salahkah insan manusia menjadi seorang KPOPERS? Ladies & gentlemen, this is UNFILTERED #3 Kritik, Saran, Donasi dan Press Release kirim ke Instagram: @minggulibur.podcast Twitter: @mglbr Donasi: saweria.co/mingguliburpodcast E-mail: mglbrpdcst@gmail.

Website: https://www.collectivemining.com/ Press Release: https://provenandprobable.com/collective-mining-significantly-expands-the-main-breccia-discovery-at-apollo-and-drills-near-surface-high-grade-mineralization-including-168-6-metres-at-2-91-g-t-gold-equivalent/ Corporate Presentation: https://www.collectivemining.com/investors/presentations/ Facebook: https://www.facebook.com/CollectiveMiningCol Twitter: https://twitter.com/CollectiveMini1 LinkedIn: https://www.linkedin.com/company/collectivemining/?originalSubdomain=co Instagram: https://www.instagram.com/collectivemining/ Youtube: https://www.youtube.com/channel/UC0J8zpCq0TNhJQePKdCrJag Collective Mining: Rapidly advancing, large scale gold-copper-silver-moly porphyry and breccia targets with related high-grade vein systems in the mining-friendly department of Caldas in Colombia Collective Mining's two projects the Guayabales (Flagship) and the San Antonio (Secondary) are situated in Marmato, an underexplored yet multi-million ounce, high-grade gold and silver district located in the Middle Cauca belt in Colombia. With six out of eleven targets drilled, the Company has made three promising grassroot discoveries to date and is awaiting assay results on a potential fourth discovery. Drilling activity continues at a brisk pace with a 20,000+ metre drill program in 2022. The Best Video on Why and When to Buy and Sell Physical Precious Metals: https://youtu.be/HFd9fc7BmAI Website| www.provenandprobable.com Call me directly at 855.505.1900 or email: Maurice@MilesFranklin.com Precious Metals FAQ - https://www.milesfranklin.com/faq-maurice/ Proven and Probable Where we deliver Mining Insights & Bullion Sales. I'm a licensed broker for Miles Franklin Precious Metals Investments (https://www.milesfranklin.com/contact/) Where we provide unlimited options to expand your precious metals portfolio, from physical delivery, offshore depositories, and precious metals IRA's. Call me directly at (855) 505-1900 or you may email maurice@milesfranklin.com. Proven and Probable provides insights on mining companies, junior miners, gold mining stocks, uranium, silver, platinum, zinc & copper mining stocks, silver and gold bullion in Canada, the US, Australia, and beyond. #provenandprobable #collectivemining

Barudak kabeh adalah tema untuk Minggulibur Podcast Updates kali ini dan beragam genre serta generasi. Semua terangkum di Minggulibur Podcast Updates 28 November 2022. Kritik, Saran, Donasi dan Press Release kirim ke Instagram: @minggulibur.podcast Twitter: @mglbr Donasi: saweria.co/mingguliburpodcast E-mail: mglbrpdcst@gmail.

In This Episode Erin and Weer'd discuss: the shooting at Club Q in Colorado Springs; the racist remarks of a New Jersey assemblyman, and the racist roots of gun control; and the unintended consequences of passing Oregon Ballot Initiative 114. Next, Weer'd sits down with Ian McCollum of Forgotten Weapons and Headstamp Publishing to discuss all the difficulties of getting Pistols of the Warlords published; and finally, Weer'd brings us part 4 of his fisk of Brady Campaign talking points, this  time on the "culture of gun violence". Did you know that we have a Patreon? Join now for the low, low cost of $4/month (that's $1/podcast) and you'll get to listen to our podcast on Friday instead of Mondays, as well as patron-only content like mag dump episodes, our hilarious blooper reels and film tracks. Main Topic: Operation Blazing Sword's Press Release on the Club Q Shooting The latest on the Colorado Springs LGBTQ nightclub shooting Army veteran Richard Fierro describes the moment he took down the Colorado nightclub gunman OSD 195: Majority rules Attorney Breaks Down Issues With Oregon's Measure 114 Democrat NJ Assemblyman McKeon makes racist remarks during carry bill meeting Ian McCollum Interview: Forgotten Weapons Head Stamp Publishing Kickstarter for Clockwork Basilisk Weer'd Audio Fisk: 186: Brady in Brief: We Respond to Common Arguments Against Gun Violence Prevention NRA calls out violence in video games, cites ‘Kindergarten Killers' Project Unloaded Goes after Video Games Assorted Calibers Podcast Ep 223: Round Table News Round-Up Assorted Calibers Podcast Ep 215: Anti-Gun Insanity  

In the American political system, the judiciary serves as an impartial, independent branch of government responsible for interpreting our laws and deciding cases and controversies. Even with these foundational principles, how do we ensure public trust in the institution? Sixth Circuit Court of Appeals Judge Bernice Donald joins Kayla Odom and Alicia Downey to reflect on the public perception of the role of the judiciary. Listen in to hear what shapes our understanding of the courts, and what the judiciary can do to ensure public confidence in the administration of justice. With special guest: Hon. Bernice B. Donald, U.S. Court of Appeals for the Sixth Circuit Related Links: Bernice B. Donald and Don R. Willett – How to counter today's tribalism and build ‘a more perfect union' – Sept. 16, 2022 Press Release, Federal appeals court judge Bernice Donald to receive Sandra Day O'Connor Award for outstanding contributions to justice – Aug. 31, 2022 Hosted by: Alicia Downey, Downey Law LLC and Kayla Odom, Corporate Counsel, Renesas

Band muda rasa orang tua ini saya kenal sebelum bassistnya (sempat) menjadi anggota band saya yang sudah berubah genre. Bagi saya Erratic Moody adalah salah satu unit yang akan menggila suatu saat dengan membawa kenecisan nya. Episode terakhir dari series The Sound Of Jatinangor bersama Erratic Moody ini membahas bagaimana bersyukurnya mereka bisa tumbuh di ranah musik Jatinangor yang amat mensupport kiprah musikal mereka dan membahas single mereka yang dirilis tahun ini bertajuk 'Good Night' yang berkolaborasi dengan rockstar murah senyum, Abyan "Acin" Nabilio dari The Panturas. So, ladies and gentlemen, this is The Sounds Of Jatinangor: Ucapan Selamat Malam Dari Erratic Moody Kritik, Saran, Donasi dan Press Release kirim ke Instagram: @minggulibur.podcast Twitter: @mglbr Donasi: saweria.co/mingguliburpodcast E-mail: mglbrpdcst@gmail.com

KISS PR, a leader in online press release distribution, makes it easier than ever to target local media outlets by launching its new PR services. KISS PR allows small businesses to achieve their maximum visibility in the local market by distributing their news releases directly to media outlets such as newspapers, television and radio stations, magazines and websites. local press release distribution by KISS PR - MAVERICKS WANTEDWhat is KISS PR NewsroomKISS PR's white-label service allows clients to take full advantage of its state-of-the-art press release distribution services without having to learn how or purchase any of the necessary software. Clients can now work with KISS PR directly on a project basis and receive customized media distribution solutions tailored to their specific needs without hiring any additional staff. Whether it's a single press release or an entire media campaign, KISS PR provides the tools and resources needed to get the job done quickly and efficiently.The Benefits of Local Press Release Distribution with KISS PRLocal press release distribution with KISS PR is a great way to reach people in your local area who may not otherwise have access to your news. By distributing press releases directly to Google News which creates local media visibility, you can ensure that your message reaches the right audiences and gets the attention it deserves. There are several benefits of using KISS PR for local press like using GEO targeting. This allows you to narrow your focus to a particular region or group, helping you get more from your press release.Why Send Press Releases Instead of Blogging? Press releases are still an effective way to reach both local and international audiences. Unlike blog posts which can be buried in search engine results, press releases are immediately indexed by major search engines and often appear at the top of related searches. This means that your news is quickly shared with the people who matter most -your potential customers- making it easier for them to find you.KISS PR's media distribution services make it easy for small businesses to reach their local audience and connect with new customers. With the launch of its PR services, KISS PR has made local press release distribution easier than ever before.What are Some Benefits of Press Releases for Local Businesses?Press releases are an effective way to build trust and credibility with your local customers. By providing them with up-to-date information about your business, you can demonstrate your commitment to transparency and customer service. Press releases also help boost visibility for small businesses by allowing them to target a wider audience than they would through traditional advertising methods. Additionally, press releases can be used to announce products, services and events which can help increase brand awareness.About KISS PRKISS PR's media distribution services make it easy for local businesses to reach their target audiences and get the attention they deserve. With its launch of PR services, KISS PR is making it easier than ever to get the word out about your business and target local media outlets. From newspapers, television and radio stations to magazines and websites, KISS PR's press release distribution services ensure maximum visibility in the local market.To learn more about KISS PR's PR services or to get started with a project today, please visit

Joining us for a conversation is Ari Sussman of Collective Mining, Colombia's Newest Exploration Company. Collective Mining has just announced another significant development coming from the flagship Guayabales Project demonstrating continuity with a new Strike of 385 Meters, Width at 350 Meters, and Vertical 825 Meters! In this interview with provide shareholders with an update on the Collective Mining's Exploration Program, which was just extended another 3,000 Metres on the back of a successful $10 Million Finance. In this video, we'll be highlighting Collective Mining and their recent Breccia expansion at the Apollo Target. Collective Mining is becoming a front runner in the junior mining space. With their flagship Guayables Project, Collective Mining is looking to materially expand their current mineral holdings. If you're interested in junior mining stocks, then you'll want to check out this video! We'll discuss Collective Mining's new project, Apollo, and what this could mean for the junior mining space. Make sure to subscribe to our channel so you never miss an update! In this video, I'm discussing the flagship Guayabales Project, specifically the Apollo Target with Aris Sussman of Collective Mining. The expansion at the Apollo gold project in Colombia, and how this could lead to further gains for Collective Mining shareholders. COLLECTIVE MINING: Listing:(TSX.V: CNL | OTCQX: CNLMF) Website: https://www.collectivemining.com/ Press Release: https://provenandprobable.com/step-out-drilling-materially-expands-the-overall-dimensions-of-collective-minings-main-breccia-discovery-at-apollo/ Corporate Presentation: https://www.collectivemining.com/investors/presentations/ Facebook: https://www.facebook.com/CollectiveMiningCol Twitter: https://twitter.com/CollectiveMini1 LinkedIn: https://www.linkedin.com/company/collectivemining/?originalSubdomain=co Instagram: https://www.instagram.com/collectivemining/ Youtube: https://www.youtube.com/channel/UC0J8zpCq0TNhJQePKdCrJag Collective Mining: Rapidly advancing, large scale gold-copper-silver-moly porphyry and breccia targets with related high-grade vein systems in the mining-friendly department of Caldas in Colombia Collective Mining's two projects the Guayabales (Flagship) and the San Antonio (Secondary) are situated in Marmato, an underexplored yet multi-million ounce, high-grade gold and silver district located in the Middle Cauca belt in Colombia. With six out of eleven targets drilled, the Company has made three promising grassroot discoveries to date and is awaiting assay results on a potential fourth discovery. Drilling activity continues at a brisk pace with a 20,000+ metre drill program in 2022. The Best Video on Why and When to Buy and Sell Physical Precious Metals: https://youtu.be/HFd9fc7BmAI Website| www.provenandprobable.com Call me directly at 855.505.1900 or email: Maurice@MilesFranklin.com Precious Metals FAQ - https://www.milesfranklin.com/faq-maurice/ Proven and Probable Where we deliver Mining Insights & Bullion Sales. I'm a licensed broker for Miles Franklin Precious Metals Investments (https://www.milesfranklin.com/contact/) Where we provide unlimited options to expand your precious metals portfolio, from physical delivery, offshore depositories, and precious metals IRA's. Call me directly at (855) 505-1900 or you may email maurice@milesfranklin.com. Proven and Probable provides insights on mining companies, junior miners, gold mining stocks, uranium, silver, platinum, zinc & copper mining stocks, silver and gold bullion in Canada, the US, Australia, and beyond. #provenandprobable #collectivemining

Membahas salah satu entitas paling anjing, paling membuat muak di ranah musik. Jadi Polisi Kok Di Skena? Kritik, Saran, Donasi dan Press Release kirim ke Instagram: @minggulibur.podcast Twitter: @mglbr Donasi: saweria.co/mingguliburpodcast E-mail: mglbrpdcst@gmail.com

Get free resources for your author business here: http://kickstartyourbooksales.com/freeIn this episode, Russell Nohelty talks with PR specialist James Emmett about how authors can maximize their direct sales public relations success with press kits, press releases and more.Welcome to the Kickstart Your Book Sales podcast with USA Today bestselling authors Russell Nohelty and Monica Leonelle, where you'll learn how to supercharge your book sales, go aggressively wide, and take your author career to the next level.Our free Kickstarter 5-Day Challenge is back! Get our secrets and tricks to completing one huge section of your Kickstarter campaign, plus get free mentoring from us throughout the challenge! Go to http://kickstartyournovel.com/challenge to sign up.The Kickstarter Accelerator is currently open in early bird pricing. Get it here, now: http://kickstartyournovel.com/buy

“I teach my clients how to get more media exposure so that they can make a bigger impact in the world”.  Angel Tuccy has hosted over 2,000 broadcasts, interviewed almost 5,000 guests, and has helped entrepreneurs & business owners attract more media, more followers, and even more customers. Angel says that it isn't rocket science, but it does require establishing yourself as a trusted resource and promoting yourself when the media comes calling. In this episode, she shares her exclusive formula with Deb. Pro Tip: You might want to (not only) download this episode, but also bookmark it as well since you'll be referring back to it often.   [00:01 9:16] Opening Segment Angel tells us about her journey into (and out of) the corporate Media/PR space From a booked out schedule to having credentials pulled preventing you from entering the building  When the unexpected happens-you pivot.     [9:17 -15:27]  How Angel works with clients to get them media exposure   Her technique will shorten the sales cycle and increasing KLT (know, like and trust) factor instantly    Teaches the formula on how to connect with journalists on a continuing basis. Two interviews a week translates into 100 fresh new audiences  The “Old School method” is a trusted, proven strategy      [15:28 - 24:34]  Bootstrapping your way through it   Start curating your own database Monetize the momentum you've gained Paid media exposure: pros and con When is your PR day?   [24:35 - 26:10] Elements of a well crafted pitch Keep press releases simple; Keep to the basics; who/what/when/where.   No explanation points. Keep it fact based Stay on their radar. Send fresh material to your list regularly Keep consistent; 2 interviews a week, 1 press release a month Fall in love with the routine    [26:11 - 28:30] Closing Segment  Connect with Angel through the links below  Follow us on social media and leave a review Final words   Connect with Angel Tuccy Website: Make Your Big Impact  Facebook: Need A Guest | Facebook Instagram: @angeltuccy Twitter:@AngelTuccy LInkedIn:  Angel Tuccy | LinkedIn Pinterest: www.pinterest.com/MediaAngel Youtube: Angel Tuccy - YouTube   Resources Mentioned on this episode HARO Help A Reporter   Here are some another episodes you might enjoy as well: Ep 117. Visibility For Profits https://cutt.ly/117Visibility4Profits Ep 91. How to Become an In Demand Speaker https://cutt.ly/91-InDemandSpeaker   Tweetable Quotes: “You can submit your press releases because they're looking for stories, they want your stories. And a press release is how you speak to them, how you pitch to them. ” -Angel Tuccy  “So while that was one of those dark days, I can look back with gratitude to the release… That now I can go off and really serve clients in a really special and unique way”. - Angel Tuccy    SUBSCRIBE & LEAVE A FIVE-STAR REVIEW and share this podcast to other growing entrepreneurs!  Get weekly tips on how to create more money and meaning doing work you love and be one of the many growing entrepreneurs in our community. CLICK HERE to join our private Facebook Group!  Connect with me on Instagram, LinkedIn, or checkout our website at www.lifeaftercorporatepodcast.com

Share this with the world, Please help get this message out to all. You can get the full text here: http://www.wobbliesandwizards.com/noble-knight-games-united-press-release/ We received a Press Release from the workers  organizing at Noble Knight Games #WeRollTogether let's unionize the  industry You can follow them on Twitter here: https://twitter.com/NkgUnited Follow on facebook here: https://www.facebook.com/NKGUnited Follow on Instagram here: https://www.instagram.com/nkgunited/ --- Send in a voice message: https://anchor.fm/wobbliesandwizards/message Support this podcast: https://anchor.fm/wobbliesandwizards/support

Updates kali ini menghadirkan, berita tentang The Battlebeats, Rollfast dan Noon Radar yang sedang menjalankan ibadah tour. Lalu juga ada berita dari phase 1 line up Playlist Love Festival dan rilisan terbaru dari pris., Ratih Putria, Salim Lubis, Rayhan Noor, Raisa dan Noah. Semua terangkum di Minggulibur Podcast Updates 21 November 2022. Kritik, Saran, Donasi dan Press Release kirim ke Instagram: @minggulibur.podcast Twitter: @mglbr Donasi: saweria.co/mingguliburpodcast E-mail: mglbrpdcst@gmail.com

Apa yang kalian bayangkan ketika hari raya tiba? Sudah pasti hiruk pikuk manusia yang senang dengan datangnya hal tersebut. Sama seperti unit indie pop asal Jatinangor ini, Hari Raya.  Kalau nama adalah doa, mereka selayaknya berdoa agar band ini senantiasa memberikan keramaian dan kesenangan seperti hari raya di kebanyakan fikiran manusia. So, ladies and gentlemen, This Is The Sounds Of Jatinangor: Keramaian Itu Bernama Hari Raya Kritik, Saran, Donasi dan Press Release kirim ke Instagram: @minggulibur.podcast Twitter: @mglbr Donasi: saweria.co/mingguliburpodcast E-mail: mglbrpdcst@gmail.com

Got a Minute? Website owner checkout today's episode of The Guy R Cook Report podcast - the Google Doc for this episode is @ 20221117 60 Best Press Release Websites | Newswire Websites ----more---- Support this podcast Subscribe where you listen to podcasts I help goal oriented business owners that run established companies to leverage the power of the internet Contact Guy R Cook @ https://guyrcook.com The Website Design Questionnaire https://guycook.wordpress.com/start-with-a-plan/ In the meantime, go ahead follow me on Twitter: @guyrcookreport Click to Tweet Be a patron of The Guy R Cook Report. Your help is appreciated.   https://guyrcook.com https://theguyrcookreport.com/#theguyrcookreport Follow The Guy R Cook Report on Podbean iPhone and Android App | Podbean   https://bit.ly/3m6TJDV Thanks for listening, viewing or reading the show notes for this episode. Vlog files for 2022 are at 2022 video episodes of The Guy R Cook ReportHave a great new year, and hopefully your efforts to Entertain, Educate, Convince or Inspire are in play vDomainHosting, Inc 3110 S Neel Place Kennewick, WA 509-200-1429

Sebuah pertanyaan paling mendasar dari kejadian gagalnya event musik bernama Fosfen Festival beserta event musik yang gagal lain nya. Bikin Event Kok Kayak Tai? Kritik, Saran, Donasi dan Press Release kirim ke Instagram: @minggulibur.podcast Twitter: @mglbr Donasi: saweria.co/mingguliburpodcast E-mail: mglbrpdcst@gmail.com

A new research paper was published on the cover of Aging (listed as "Aging (Albany NY)" by Medline/PubMed and "Aging-US" by Web of Science) Volume 14, Issue 21, entitled, “IGF1 gene therapy in middle-aged female rats delays reproductive senescence through its effects on hypothalamic GnRH and kisspeptin neurons.” The process of aging is the result of progressive loss of homeostasis and functional body impairment, including the central nervous system, where the hypothalamus plays a key role in regulating aging mechanisms. The consequences of aging include a chronic proinflammatory environment in the hypothalamus that leads to decreased secretion of gonadotropin-releasing hormone (GnRH) and impairs kisspeptin neuron functionality. In this new study, researchers Franco Juan Cruz Dolcetti, Eugenia Falomir-Lockhart, Francisco Acuña, Macarena Lorena Herrera, Sofia Cervellini, Claudio Gustavo Barbeito, Daniela Grassi, Maria-Angeles Arevalo, and María José Bellini from Consejo Nacional de Investigaciones Científicas y Técnicas (UNC-CONICET), Universidad Nacional de La Plata, Autonomous University of Madrid, Instituto Cajal, and Instituto de Salud Carlos III investigated the effect of insulin-like growth factor 1 (IGF1) gene therapy on hypothalamic kisspeptin/GnRH neurons and on microglial cells, that mediate the inflammatory process related with the aging process. “The aim of the present study is to investigate the effect of IGF1 gene therapy on estrous cycle, kisspeptin and GnRH neurons, and microglial cells in middle-aged female rats.” The results show that IGF1 rats have higher kisspeptin expression in the anteroventral periventricular (AVPV) nucleus and higher immunoreactivity of GnRH in the arcuate nucleus and median eminence. In addition, IGF1-treated animals exhibit increased numbers of Iba1+ microglial cells and MHCII+/Iba1+ in the AVPV and arcuate nuclei. In conclusion, IGF1 gene therapy maintains kisspeptin production in the AVPV nucleus, induces GnRH release in the median eminence, and alters the number and reactivity of microglial cells in middle-aged female rats. The researchers suggest that IGF1 gene therapy may have a protective effect against reproductive decline. “Based on our findings, we propose IGF1 gene therapy to delay reproductive senescence as a potential strategy to optimize lifespan and combat age-related health problems in women.” DOI: https://doi.org/10.18632/aging.204360 Corresponding Authors: Maria-Angeles Arevalo - arevalo@cajal.csic.es, and María José Bellini - mariajosebellini@med.unlp.edu.ar Keywords: IGF1, gene therapy, reproductive senescence, GnRH, kisspeptin, microglia Sign up for free Altmetric alerts about this article: https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.204360 About Aging-US: Launched in 2009, Aging (Aging-US) publishes papers of general interest and biological significance in all fields of aging research and age-related diseases, including cancer—and now, with a special focus on COVID-19 vulnerability as an age-dependent syndrome. Topics in Aging go beyond traditional gerontology, including, but not limited to, cellular and molecular biology, human age-related diseases, pathology in model organisms, signal transduction pathways (e.g., p53, sirtuins, and PI-3K/AKT/mTOR, among others), and approaches to modulating these signaling pathways. Please visit our website at www.Aging-US.com​​ and connect with us: SoundCloud – https://soundcloud.com/Aging-Us Facebook – https://www.facebook.com/AgingUS/ Twitter – https://twitter.com/AgingJrnl Instagram – https://www.instagram.com/agingjrnl/ YouTube – https://www.youtube.com/agingus​ LinkedIn – https://www.linkedin.com/company/aging/ Reddit – https://www.reddit.com/user/AgingUS Pinterest – https://www.pinterest.com/AgingUS/ For media inquiries, please contact media@impactjournals.com.

Do you want to get your press release approved for AP News? There's no need to hire a publicist - you can do it yourself! Just follow these simple steps from Tik Toker Agnes Zang:1. Keep it simple and straightforward - make sure your press release is easy to read and understand.2. Keep it newsworthy - your press release should be interesting and relevant.3. Follow the guidelines - check the AP News website for submission guidelines and requirements.4. Include a catchy headline - make sure your headline is attention-grabbing and informative.5. Make it visually appealing - use images, infographics, or videos to make your press release more engaging.6. Proofread and edit - before you submit your press release, make sure it is free of errors.By following these simple tips, you can increase your chances of getting your press release approved for AP News. Good luck!Tiktok video link here > Learn how to get your press release approved for AP News -.

Do you want to get your press release approved for AP News? There's no need to hire a publicist - you can do it yourself! Just follow these simple steps from Tik Toker Agnes Zang:1. Keep it simple and straightforward - make sure your press release is easy to read and understand.2. Keep it newsworthy - your press release should be interesting and relevant.3. Follow the guidelines - check the AP News website for submission guidelines and requirements.4. Include a catchy headline - make sure your headline is attention-grabbing and informative.5. Make it visually appealing - use images, infographics, or videos to make your press release more engaging.6. Proofread and edit - before you submit your press release, make sure it is free of errors.By following these simple tips, you can increase your chances of getting your press release approved for AP News. Good luck!Tiktok video link here > Learn how to get your press release approved for AP News -.

Let's breathe for the U of V victims of a field trip gone wrong. We got our third ever black governor, but we could still use plenty of future candidates of color to fill up these new classes in congress. Beyoncé's album broke all through the soul of the Grammy nominations. Let's breathe and get these Frontier refunds…Press Release- https://www.transportation.gov/briefing-room/more-600-million-refunds-returned-airline-passengers-under-dot-rules-backed-new . Grammy Nominees- https://www.grammy.com/news/2023-grammy-nominations-complete-winners-nominees-list --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app

Mulai dari sisi introvert Mono & Roze, keajaiban Glory Of Love, tahun paling biru dari Girl And Her Bad Mood. Lalu, definisi surga menurut Romantic Echoes, single terkencang dari Polka Wars hingga kisah murah dari Sore. Semua terangkum dalam Minggulibur Podcast Updates Kritik, Saran, Donasi dan Press Release kirim ke Instagram: @minggulibur.podcast Twitter: @mglbr Donasi: saweria.co/mingguliburpodcast E-mail: mglbrpdcst@gmail.com

11/10 Hour 3 Ron Rivera presser - 11:49

There is a better way for Small Businesses to handle their Press Release distribution through eReleases. Rather than spend thousands of dollars on hiring PR Firms, use the eReleases platform and their friendly editors Follow this link to find out More https://efriendlytools.com/ereleases-online-traffic-small-business/

My guest on the show today is Brian Balbirnie, CEO of Issuer Direct Corporation (NYSE American: ISDR). Issuer Direct® is a leading communications and compliance company, providing solutions for both Public Relations and Investor Relations Professionals. Our comprehensive solutions are used by thousands of customers from emerging startups to multi-billion dollar global brands, ensuring their most important moments are reaching the right audiences, via our industry leading newswire, IR website solutions, events technology, and compliance solutions. For full disclosure, we're a customer of Issuer Direct's, using their events software and webcast solutions for our investor conferences, as well as publishing press releases through the Accesswire platform. I've also known Brian for pretty much my entire career working in MicroCaps and would consider him both a friend and colleague, and have always admired how he's gone about building and running Issuer Direct over the years. We've done a couple interviews over the years, but thought it was time for us to geek out on the media and news business, as well as discuss: Issuer Direct's just announced acquisition of Newswire and what the biggest acquisition in the company's history means for them moving forward the in and outs of the Press Release and News Distribution business and industry Lessons learned from mistakes made and what inspired the founding of Issuer Direct, and; Brian's vision for the company in 3-5 years With that, please enjoy my conversation with Brian Balbirnie, CEO of Issuer Direct Corporation.For more information about Issuer Direct Corporation, please visit: https://www.issuerdirect.com/ This podcast was recorded and is being made available by SNN, Inc. (together with its affiliates and its and their employees, “SNN”) solely for informational purposes. SNN is not providing or undertaking to provide any financial, economic, legal, accounting, tax, or other advice in or by virtue of this podcast. The information, statements, comments, views, and opinions provided in this podcast are general in nature, and such information, statements, comments, views, and opinions, and the viewing of/listening to this podcast are not intended to be and should not be construed as the provision of investment advice by SNN. The information, statements, comments, views, and opinions expressed in this podcast do not constitute and should not be construed as an offer to buy or sell any securities or to make or consider any investment or other course of action. The information, statements, comments, views, and opinions expressed in this podcast (including by guest speakers who are not officers, employees, or agents of SNN) are not necessarily those of SNN and may not be current. Reference to any specific third-party entity, product, service, materials, or content does not constitute an endorsement or recommendation by the SNN. SNN assumes no responsibility or liability for the accuracy or completeness of the content contained in third party materials or on third party sites referenced in this podcast or the compliance with applicable laws of such materials and/or links referenced herein. The views expressed by guest speakers are their own and their appearance on this podcast does not imply an endorsement of them or any entity they represent. SNN does not make any representation or warranty as to the accuracy or completeness of any of the information, statements, comments, views, or opinions contained in this podcast, which may include forward-looking statements where actual results may differ materially. SNN does not undertake any obligation whatsoever to provide any form of update, amendment, change, or correction to any of the information, statements, comments, views or opinions set forth in this podcast. SNN EXPRESSLY DISCLAIMS ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR OTHER DAMAGES ARISING OUT OF ANY INDIVIDUAL'S USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE, THIS PODCAST OR THE INFORMATION PRESENTED IN THIS PODCAST. By accessing this podcast, the listener acknowledges that the entire contents and design of this podcast, are the property of SNN, or used by SNN with permission, and are protected under U.S. and international copyright and trademark laws. Except as otherwise provided herein, users of this podcast may save and use information contained in the podcast only for personal or other non-commercial educational purposes. No other use, including without limitation, reproduction, retransmission, or editing of this podcast may be made without the prior written consent of SNN.

The girls recently got the opportunity to chat with Adriana Alejandre, LMFT, the founder of Latinx Therapy! Adriana gave Glowing Up Latina the inside scoop on her partnership with Breyer's Ice Cream to launch Conversaciones Vainilla – a program to help encourage, inspire and facilitate meaningful conversations amongst Hispanic families. Press Release: https://finance.yahoo.com/news/breyers-launches-conversaciones-vainilla-facilitate-140000902.html Digital Toolkit (English): https://latinxtherapy.com/wp-content/uploads/2022/07/Conversaciones-Vainilla-Digital-Toolkit.pdf Digital Toolkit (Spanish): https://latinxtherapy.com/wp-content/uploads/2022/07/Conversaciones-Vainilla-SPA-Digital-Toolkit.pdf You can find Latinx Therapy on Instagram: @latinxtherapy or at their website latinxtherapy.com. You can find Adriana on Instagram: @latinxtherapist. - Follow us on Instagram @glowinguplatina! Email us some love at glowinguplatina@gmail.com. Visit our website: www.glowinguplatina.com. Listen to the official Glowing Up Latina on Apple Music or Spotify. BLAEKER / Tequila Shawty (Instrumental) / Courtesy of www.epidemicsound.com.

Ye, Irving, Stephen, Zaya, Griner, Oprah, Sheryl Lee Ralph. Oh and Vote! Definitely go and do that y'all! Press Release: https://www.prnewswire.com/news-releases/the-wait-is-over-the-womens-sports-network-has-arrived-301666330.html . --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app

A new research perspective was published in Aging (listed as "Aging (Albany NY)" by MEDLINE/PubMed and "Aging-US" by Web of Science) Volume 14, Issue 20, entitled, “Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice.” On October 24, 2022, Mikhail Blagosklonny, M.D., Ph.D. from Roswell Park Comprehensive Cancer Center published a riveting research perspective discussing the clinical application of early-life rapamycin treatment and its ability to reprogram aging, based on the hyperfunction theory. “Making provocative headlines, three outstanding publications demonstrated that early-life treatment with rapamycin, including treatments during developmental growth, extends lifespan in animals, confirming predictions of hyperfunction theory, which views aging as a quasi-program (an unintended continuation of developmental growth) driven in part by mTOR. Despite their high theoretical importance, clinical applications of two of these studies in mice, Drosophila and Daphnia cannot be implemented in humans because that would require growth retardation started at birth. A third study demonstrated that a transient (around 20% of total lifespan in Drosophila) treatment with rapamycin early in Drosophila adult life is as effective as lifelong treatment, whereas a late-life treatment is not effective. However, previous studies in mice demonstrated that a transient late-life treatment is highly effective. Based on hyperfunction theory, this article attempts to reconcile conflicting results and suggests the optimal treatment strategy to extend human lifespan.” DOI: https://doi.org/10.18632/aging.204354 Corresponding Author: Mikhail V. Blagosklonny - Corresponding Email: Blagosklonny@oncotarget.com Video - https://www.youtube.com/watch?v=Br7iD48fKF4 Keywords: senescence, gerostatics, geroscience, sirolimus, healthspan Sign up for free Altmetric alerts about this article: https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.204354 About Aging-US: Launched in 2009, Aging (Aging-US) publishes papers of general interest and biological significance in all fields of aging research and age-related diseases, including cancer—and now, with a special focus on COVID-19 vulnerability as an age-dependent syndrome. Topics in Aging go beyond traditional gerontology, including, but not limited to, cellular and molecular biology, human age-related diseases, pathology in model organisms, signal transduction pathways (e.g., p53, sirtuins, and PI-3K/AKT/mTOR, among others), and approaches to modulating these signaling pathways. Please visit our website at www.Aging-US.com​​ and connect with us: SoundCloud – https://soundcloud.com/Aging-Us Facebook – https://www.facebook.com/AgingUS/ Twitter – https://twitter.com/AgingJrnl Instagram – https://www.instagram.com/agingjrnl/ YouTube – https://www.youtube.com/agingus​ LinkedIn – https://www.linkedin.com/company/aging/ Reddit – https://www.reddit.com/user/AgingUS Pinterest – https://www.pinterest.com/AgingUS/ For media inquiries, please contact media@impactjournals.com Aging (Aging-US) Journal Office 6666 E. Quaker Str., Suite 1B Orchard Park, NY 14127 Phone: 1-800-922-0957, option 1

A new research paper was published in Oncotarget's Volume 13 on October 20, 2022, entitled, “Nectin-4 is widely expressed in head and neck squamous cell carcinoma.” Nectin-4 has been successfully established as a target molecule in locally advanced and metastatic bladder cancer. An antibody-drug conjugate (enfortumab-vedotin) directed against nectin-4 has shown marked tumor remission rates in this tumor type, which is known for high expression rates of nectin-4. As head and neck cancer and urothelial carcinomas share morphological and molecular similarities, researchers Christine Sanders, Jan-Frederic Lau, Dimo Dietrich, Sebastian Strieth, Peter Brossart, and Glen Kristiansen from University Medical Center Bonn and University Hospital Bonn aimed to evaluate Nectin-4 expression in head and neck squamous cell carcinoma (HNSCC). A previously described and clinically characterized cohort of HNSCC (n = 159) was analyzed by immunohistochemistry for Nectin-4 expression. The expression data was correlated to clinico-pathological parameters including patient outcome. Nectin-4 was found in 86.2% of HNSCC, with medium/high expression seen in 32.7% of cases. Non smokers and p16 positive HNSCC showed a higher expression of Nectin-4 (p < 0.005). There was no correlation of Nectin-4 with grading or tumor stage. Nectin-4 positive tumors showed significantly better survival (log rank p = 0.006). “Similar to urothelial carcinoma, Nectin-4 is found in the majority of HNSCC, which clearly warrants further studies to clarify if HNSCC also respond to targeted therapy with enfortumab-vedotin. Moreover, expression of Nectin-4 is associated with HPV infection and may serve as a prognostic marker in HNSCC.” DOI: https://doi.org/10.18632/oncotarget.28299 Correspondence to: Glen Kristiansen - Email: glen.kristiansen@ukbonn.de Video - https://www.youtube.com/watch?v=tDY21YpFsKc Keywords: Nectin-4, enfortumab-vedotin, HNSCC, p16 About Oncotarget: Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media: Twitter – https://twitter.com/Oncotarget Facebook – https://www.facebook.com/Oncotarget YouTube – www.youtube.com/c/OncotargetYouTube Instagram – https://www.instagram.com/oncotargetjrnl/ LinkedIn – https://www.linkedin.com/company/oncotarget/ Pinterest – https://www.pinterest.com/oncotarget/ LabTube – https://www.labtube.tv/channel/MTY5OA SoundCloud – https://soundcloud.com/oncotarget For media inquiries, please contact: media@impactjournals.com Oncotarget Journal Office 6666 East Quaker Str., Suite 1A Orchard Park, NY 14127 Phone: 1-800-922-0957 (option 2)

Small Businesses face tremendous challenges when trying to broadcast about their products and services due to high costs in advertising, marketing and hiring PR Firms. There is a better alternative with eReleases Press Distribution service. For more information, Click on the below link https://efriendlytools.com/ereleases-online-traffic-small-business/

A new research paper was published on the cover of Aging (listed as "Aging (Albany NY)" by Medline/PubMed and "Aging-US" by Web of Science) Volume 14, Issue 20, entitled, “Downregulation of senescence-associated secretory phenotype by knockdown of secreted frizzled-related protein 4 contributes to the prevention of skin aging.” There is growing evidence that the appearance and texture of the skin that is altered during the aging process are considerably enhanced by the accumulation of senescent dermal fibroblasts. These senescent cells magnify aging via an inflammatory, histolytic, and senescence-associated secretory phenotype (SASP). Secreted frizzled-related protein 4 (SFRP4) was previously determined to be expressed in dermal fibroblasts of aging skin, and its increased expression has been shown to promote cellular senescence. However, its role in the SASP remains unknown. In this new study, researchers Kento Takaya, Toru Asou and Kazuo Kishi from Keio University School of Medicine's Department of Plastic and Reconstructive Surgery investigated the classical model of skin fibroblasts based on Hayflick's mitotic limit, the observation of SFRP4 expression in replicating senescent cells, and the effect of regulating this on the suppression of SASP and aging skin. “These results may contribute to the development of new therapies to ameliorate skin aging.” The researchers found that SFRP4 was significantly expressed in p16ink4a-positive human skin fibroblasts and that treatment with recombinant SFRP4 promoted SASP and senescence, whereas siRNA knockdown of SFRP4 suppressed SASP. They also found that knockdown of SFRP4 in mouse skin ameliorates age-related reduction of subcutaneous adipose tissue, panniculus carnosus muscle layer, and thinning and dispersion of collagen fibers. These findings suggest a potential candidate for the development of new skin rejuvenation therapies that suppress SASP. “This study shows that SFRP4, which is specifically expressed in aged p16ink4a-positive skin fibroblasts, contributes to SASP, and that treatment with SFRP4 causes worsening of this phenotype. To the best of our knowledge, the present study is the first to report that the suppression of SFRP4 expression in vivo ameliorates skin aging-related phenotypes, that is, adipose tissue atrophy and collagen fiber thinning, via SASP suppression.” DOI: https://doi.org/10.18632/aging.204273 Corresponding Author: Kento Takaya - Email: kento-takaya312@keio.jp Keywords: skin, fibroblast, SASP, SFRP4 Sign up for free Altmetric alerts about this article: https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.204273 About Aging-US: Launched in 2009, Aging (Aging-US) publishes papers of general interest and biological significance in all fields of aging research and age-related diseases, including cancer—and now, with a special focus on COVID-19 vulnerability as an age-dependent syndrome. Topics in Aging go beyond traditional gerontology, including, but not limited to, cellular and molecular biology, human age-related diseases, pathology in model organisms, signal transduction pathways (e.g., p53, sirtuins, and PI-3K/AKT/mTOR, among others), and approaches to modulating these signaling pathways. Please visit our website at www.Aging-US.com​​ and connect with us: SoundCloud – https://soundcloud.com/Aging-Us Facebook – https://www.facebook.com/AgingUS/ Twitter – https://twitter.com/AgingJrnl Instagram – https://www.instagram.com/agingjrnl/ YouTube – https://www.youtube.com/agingus​ LinkedIn – https://www.linkedin.com/company/aging/ Reddit – https://www.reddit.com/user/AgingUS Pinterest – https://www.pinterest.com/AgingUS/ For media inquiries, please contact media@impactjournals.com. Aging (Aging-US) Journal Office 6666 E. Quaker Str., Suite 1B Orchard Park, NY 14127 Phone: 1-800-922-0957, option 1

The Press Conference is on Tuesday, Nov. 1, at 12 noon EST via ZOOM. To participate, register here:https://us02web.zoom.us/meeting/register/tZIoc-qrrzgiH9ChRc-8-Usflk_N81ZAA5ADAfter registering, you will receive a confirmation email containing information about joining the meeting.Read the Press Release for info,https://www.savedandloved.com/post/stop-white-coat-killers-truth-for-health-fnd-press-conference-nov-1-2022-12-pm-estBuy me a coffee:https://www.buymeacoffee.com/savedandloved.Please subscribe and donate to my site, www.savedandloved.com

In this episode of the Morning Upgrade podcast I talk with Mickie Kennedy about his morning routine,  growing your business through change, press releases, poetry, pushing through hard projects and more. 

BUFFALO, NY- October 27, 2022 – On September 15, 2022, Oncotarget was accepted again for indexing by MEDLINE. Oncotarget is now indexed by MEDLINE/PubMed and PubMed Central/PubMed. *** The United States government is firmly committed to making credible biomedical research available to the public. In operation since 1996, PubMed is an online biomedical literature database operated by the U.S. National Institutes of Health (NIH). PubMed provides free access to over 34 million citations from MEDLINE, PubMed Central (PMC) and the National Center for Biotechnology Information databases. Started back in the 1960s, MEDLINE is a large bibliographic citation and abstract database for life science articles in journals and other scientific publications. MEDLINE now contains more than 29 million references to articles in over 5,200 journals. In 2000, PMC was launched as a free, full-text archive of biomedical and life sciences journal literature. Both MEDLINE and PMC are operated by the NIH's National Library of Medicine. Importantly, PubMed and MEDLINE use the same controlled vocabulary thesaurus, called Medical Subject Headings, or MeSH, to ensure that content is easily searchable and properly indexed. The vast scope of scholarly publications in MEDLINE is why Oncotarget is proud to have its papers indexed by this database. Oncotarget, launched in 2010, is a peer-reviewed, open-access and primarily oncology-focused biomedical journal. This journal has international reach—publishing research from world-renowned institutions. The cornerstones of Oncotarget's publishing practices are insightful peer review, scientific integrity, rigorous ethical standards, up-to-date tools and resources, and a commitment to local and scientific communities. Oncotarget aims to maximize research impact, eliminate borders between specialties and foster the application of basic and clinical science. To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media: Twitter – https://twitter.com/Oncotarget Facebook – https://www.facebook.com/Oncotarget YouTube – www.youtube.com/c/OncotargetYouTube Instagram – https://www.instagram.com/oncotargetjrnl/ LinkedIn – https://www.linkedin.com/company/oncotarget/ Pinterest – https://www.pinterest.com/oncotarget/ LabTube – https://www.labtube.tv/channel/MTY5OA SoundCloud – https://soundcloud.com/oncotarget For media inquiries, please contact media@impactjournals.com

Need to increase your brand's visibility in the search results, or get a new product announcement noticed - but without breaking the bank? LinkDaddy can help, with affordable, professional, unique press releases that get distributed to a huge network of media partners. Visit https://www.linkdaddy.shop/premium-press-release-distribution

Getting exposure for your nonprofit can lead to better fundraising totals and bigger partnerships, bringing you closer to achieving your mission. And when people want exposure, they naturally turn to press releases. But many nonprofits are disappointed when their fundraiser or program launch doesn't become front-page news. How can you learn to use press releases to effectively level-up your nonprofit? Enter Mickie Kennedy, the Founder and President of eReleases, the small business leader for press release distribution, now celebrating 22 years in business. In this episode, the self-described Press Release Ninja shares his tips for helping you increase your visibility and credibility by doing press releases better. We'll talk about the common mistakes nonprofits make with press releases, how to create ‘hooks' that journalists can't resist, and how a single press release created millions of dollars of revenue for one of his clients. Thanks for listening and be sure to subscribe for new episodes every week!

A new review paper was published in Aging (listed as "Aging (Albany NY)" by MEDLINE/PubMed and "Aging-US" by Web of Science) Volume 14, Issue 19, entitled, “RNA modifications in aging-associated cardiovascular diseases.” Cardiovascular disease (CVD) is a leading cause of morbidity and mortality worldwide that bears an enormous healthcare burden. Aging is a major contributing factor to CVDs. Functional gene expression network during aging is regulated by mRNAs transcriptionally and by non-coding RNAs epi-transcriptionally. RNA modifications alter the stability and function of both mRNAs and non-coding RNAs and are involved in differentiation, development and diseases. In this new review paper, researchers Xinyu Yang, Priyanka Gokulnath, H. Immo Lehmann, Zhitao Hou, Sun Yang, Liangzhen You, Guoxia Zhang, Yanwei Xing, Ji Lei, Guoping Li, Shuwen Guo, and Hongcai Shang from Fangshan Hospital and Dongzhimen Hospital (affiliated with Beijing University of Chinese Medicine), Massachusetts General Hospital, Harvard Medical School, Heilongjiang University of Chinese Medicine, and Chinese Academy of Chinese Medical Sciences reviewed major chemical RNA modifications on mRNAs and non-coding RNAs, including N6-adenosine methylation, N1-adenosine methylation, 5-methylcytidine, pseudouridylation, 2′ -O-ribose-methylation, and N7-methylguanosine, in the aging process with an emphasis on cardiovascular aging. They also summarize the currently available methods to detect RNA modifications and the bioinformatic tools to study RNA modifications. “More importantly, we discussed the specific implication of the RNA modifications on mRNAs and non-coding RNAs in the pathogenesis of aging-associated CVDs, including atherosclerosis, hypertension, coronary heart diseases, congestive heart failure, atrial fibrillation, peripheral artery disease, venous insufficiency, and stroke.” DOI: https://doi.org/10.18632/aging.204311 Corresponding Authors: Guoping Li; Shuwen Guo; Hongcai Shang - Corresponding Emails: gli21@mgh.harvard.edu; guo1163@163.com; shanghongcai@bucm.edu.cn Keywords: RNA modifications, aging, aging-related cardiovascular diseases, epitranscriptome Sign up for free Altmetric alerts about this article: https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.204311 About Aging-US Launched in 2009, Aging-US publishes papers of general interest and biological significance in all fields of aging research and age-related diseases, including cancer—and now, with a special focus on COVID-19 vulnerability as an age-dependent syndrome. Topics in Aging-US go beyond traditional gerontology, including, but not limited to, cellular and molecular biology, human age-related diseases, pathology in model organisms, signal transduction pathways (e.g., p53, sirtuins, and PI-3K/AKT/mTOR, among others), and approaches to modulating these signaling pathways. Please visit our website at https://www.Aging-US.com​​ and connect with us: SoundCloud - https://soundcloud.com/Aging-Us Facebook - https://www.facebook.com/AgingUS/ Twitter - https://twitter.com/AgingJrnl Instagram - https://www.instagram.com/agingjrnl/ YouTube - https://www.youtube.com/agingus​ LinkedIn - https://www.linkedin.com/company/aging/ Pinterest - https://www.pinterest.com/AgingUS/ Media Contact 18009220957 MEDIA@IMPACTJOURNALS.COM

Hi Fam! You are listening to the happy market research podcast.  Be warned, today's episode is a bit self serving.  In 2019, I co-founded HubUX. A research operation platform for private panel management, DIY recruitment and qualitative automation. Why? Because opinions are moving fast AF. In fact, Gen Z defines themself as the generation that adapts to changing trends. Brands don't even have time to create ads that can benefit from trends. By the time these trends hit their radar they are already on the down in favor of something else. Keeping track of today's consumers is like watching humming birds on crack.  Its a bit fun, but impossible to do for very long. At the same time, recruiting quality particpants for either qual or quant is getting harder and more time consuming.  HubUX was setup to solve this. How? By recruiting on social meida platforms like TikTok and screening particpants via a robust survey tool that includes video auditions.  Today, about 60% of the projects done on hubux are surveys. These surveys include several video openends. The rest of the projects are automating IDIs and Focus Group workflow. With the activity on our platform being video data collection our clients have been asking for a way to quickly analyze their video data.  This lead us to a decision: Build a video analytics tool (this is really really hard by the way) or partner with the leader in video analytics, Voxpopme.  I reached out to their leadership.  After a few conversations we quickly came to the conclusion that combining forces would increase the probability that we own the video feedback space.  On October 26th, 2023 we announced the merger of hubux and voxpop.  From my view, the combination of automated research operations and video analytics represent the biggest change in our industry since the invention of surveys in the 1920s, focus groups in 1937, and online surveys in the 1990s.   You all know me and my histroy. I may have done the first online survey for commerical purposes in the 90s while at Macro Consulting. Dispite the fact that my dislexia makes reading a bit challenging, my brain helps me to see patterns in the market. And it is abundantly clear that video will play a major part in every modern brands' insights department.  The following is the recording of the live announcement that was streamed on 20+ platforms with Jenn Voguel, CRO, and Voxpop cofounder and CPO, Andy Barraclough.  Enjoy! Find Voxpopme Online: Website: https://site.voxpopme.com/LinkedIn: https://www.linkedin.com/company/voxpopme/?originalSubdomain=uk Press Release: https://site.voxpopme.com/news/industry-leading-qualitative-tech-platform-voxpopme-acquires-research-ops-platform-hubux/  Find HubUX Online: Website: https://hubux.com/ LinkedIn: https://www.linkedin.com/company/hubuxr/  Find Jamin Online: Email: jamin@happymr.com LinkedIn: www.linkedin.com/in/jaminbrazilTwitter: www.twitter.com/jaminbrazil  Find Us Online:  Twitter: www.twitter.com/happymrxp LinkedIn: www.linkedin.com/company/happymarketresearch Facebook: www.facebook.com/happymrxp Website: www.happymr.com  Music: “Clap Along” by Auditionauti: https://audionautix.com

As a public relations veteran, Jody Fisher brings his vast knowledge to this episode of The PR Maven® Podcast. Jody shares some of his secrets to success, in particular, always trying to be helpful to the reporter rather than just trying to get a result for your client. He explains how he trains his clients for media interviews by making sure they are confident in the messages they want to get across. Jody also explains why the press release is not dead and emphasized the use of video to get results.   3:51 – Jody describes his career path, including a shift from radio to PR.    8:06 – Jody explains how to think like a reporter and have a sense of what is newsworthy. The key: always try to help the reporter.   17:00 – Jody shares how he prepares clients for media interviews by making sure they are confident, but not comfortable.   23:59 – Jody talks about why press releases are not dead and how the media uses them today.   28:32 – Jody lists how press releases can be repurposed in your content marketing strategy.   30:45 – Jody emphasizes the importance of video and how television media has had a video philosophy flip since COVID.   34:43 – Jody provides some resources he finds helpful.     Quote   “There's this horrible perception about PR people that we are somehow disingenuous or not completely honest, and it boils down to that four-letter word, nails on a chalkboard for me, spin. Good PR people don't spin because we don't have to. We have good stories and we want to give good stories to reporters to inform their audience of the interesting, funny, comical, essential, critical or lifesaving information that we have access to through our clients. I always say that PR people have just as much interest in helping the reporter as we do our client. It's not mutually exclusive.”– Jody Fisher, vice president of public relations at Austin Williams.     Links:   Nancy's Episode on The PR Podcast: https://podcasts.apple.com/us/podcast/93-nancy-marshall-the-pr-maven-on-building-a-personal-brand/id1528904589?i=1000575350537   Warren Weeks on The PR Podcast: https://podcasts.apple.com/us/podcast/90-warren-weeks-on-media-training-and-the-worst/id1528904589?i=1000570289127   Molly McPherson: https://mollymcpherson.com/   Indestructible PR Podcast: https://mollymcpherson.com/podcast/     Listen to Molly McPherson's episode on The PR Maven® Podcast.     About the guest:      Jody Fisher is vice president of public relations at Austin Williams, a Long Island based marketing, advertising and digital agency. Jody leads the division that represents clients across healthcare, higher education, financial services, non-profit and real estate industries. In his 25-year career as a PR leader, he has worked with New York based clients that include the Intrepid Sea, Air & Space Museum, Silverstein Properties at the World Trade Center, Friends of the High Line, the New York Post and Wall Street Journal and many more. He is also the host of The PR Podcast, a weekly show that spotlights guests with expertise in public relations and the news business. He's also a former NYC radio reporter and brings his newsroom savvy to his clients to create actionable PR programs.  Looking to connect:             Email: jodyfisher@live.com   LinkedIn: https://www.linkedin.com/in/jodyfisher/   Twitter: @jodyfisher  Website: www.jodyfisherpr.com   Podcast: https://podcasts.apple.com/us/podcast/the-pr-podcast/id1528904589  

A new research paper was published in Oncotarget's Volume 13 on October 19, 2022, entitled, “Therapeutic efficacy of the humanized JAA-F11 anti-Thomsen-Friedenreich antibody constructs H2aL2a and H3L3 in human breast and lung cancer xenograft models.” The Thomsen-Friedenreich antigen (TF-Ag-α) is found on ~85% of human carcinomas but is cryptic on normal tissue. The humanized, highly specific hJAA-F11-H2aL2a and -H3L3 antibodies target TF-Ag-α without binding to TF-Ag-beta (found on surface glycolipids of some normal cells). “The relative affinity of H3L3 is 17 times that of H2aL2a, which would seem to favor superior efficacy, however, increased affinity can result in less tumor penetration.” In a new study, researchers Diala Ghazal, Fatma Zalzala, John C. Fisk, Swetha Tati, Loukia G. Karacosta, Susan Morey, James R. Olson, Sally Quataert, Grace K. Dy, and Kate Rittenhouse-Olson from For-Robin, Inc, University at Buffalo, University of Rochester, and Roswell Park Comprehensive Cancer Center Buffalo aimed to assess the potential therapeutic efficacy of these antibodies by treating four human cancer- mouse xenograft models with H2aL2a and H3L3. The tumor xenograft models used were human non-small cell lung cancer, H520, and small cell lung cancer, HTB171 in nude mice and human triple negative breast cancer, MDA-MB-231 and HCC1806 in SCID mice. H2aL2a significantly decreased tumor growth in both breast and both lung cancer models. H2aL2a showed statistically equal or better efficacy than H3L3 and has superior production capabilities. These results suggest that H2aL2a may be superior as a naked antibody, as an antibody drug conjugate or as a radiolabeled antibody, however the higher affinity of H3L3 may lead to better efficacy in bi-specific therapies in which the binding is decreased due to the presence of only one TF-Ag-α binding site. “In conclusion, both H2aL2a and H3L3 humanized antibodies to TF-Ag-α show efficacy in in vivo xenograft models of human tumors in SCID and nude mice and thus hold promise as therapeutics for breast and lung cancer. H2aL2a significantly decreased tumor growth rate in both breast cancer and both lung cancer models tested. H2aL2a is equal to or better than H3L3 in four of the four models and H2aL2a cell lines have far superior antibody production capabilities under the conditions tested.” DOI: https://doi.org/10.18632/oncotarget.28282 Correspondence to: Kate Rittenhouse-Olson - krolson@buffalo.edu Keywords: hJAA-F11, TF-Ag, Thomsen-Friedenreich antigen, tumor immunotherapy, translational oncology About Oncotarget: Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media: Twitter - https://twitter.com/Oncotarget Facebook - https://www.facebook.com/Oncotarget YouTube – www.youtube.com/c/OncotargetYouTube Instagram - https://www.instagram.com/oncotargetjrnl/ LinkedIn - https://www.linkedin.com/company/oncotarget/ Pinterest - https://www.pinterest.com/oncotarget/ LabTube - https://www.labtube.tv/channel/MTY5OA SoundCloud - https://soundcloud.com/oncotarget For media inquiries, please contact: media@impactjournals.com. Oncotarget Journal Office 6666 East Quaker Str., Suite 1A Orchard Park, NY 14127 Phone: 1-800-922-0957 (option 2)

A new research paper was published in Oncotarget's Volume 13 on October 19, 2022, entitled, “Platelet-derived growth factor (PDGF) cross-signaling via non-corresponding receptors indicates bypassed signaling in colorectal cancer.” Platelet-derived growth factor (PDGF) signaling, besides other growth factor-mediated signaling pathways like vascular endothelial growth factor (VEGF) and epidermal growth factor (EGF), seems to play a crucial role in tumor development and progression. Previously, researchers Romana Moench, Martin Gasser, Karol Nawalaniec, Tanja Grimmig, Amrendra K. Ajay, Larissa Camila Ribeiro de Souza, Minghua Cao, Yueming Luo, Petra Hoegger, Carmen M. Ribas, Jurandir M. Ribas-Filho, Osvaldo Malafaia, Reinhard Lissner, Li-Li Hsiao, and Ana Maria Waaga-Gasser, from Harvard Medical School, Shenzhen Traditional Chinese Medicine Hospital, University of Wuerzburg, and Mackenzie Evangelical Faculty of Paraná, recently provided evidence for upregulation of PDGF expression in UICC stage I–IV primary colorectal cancer (CRC) and demonstrated PDGF-mediated induction of PI3K/Akt/mTOR signaling in CRC cell lines. In their new study, the researchers sought to follow up on our previous findings and explore the alternative receptor cross-binding potential of PDGF in CRC. “Our analysis of primary human colon tumor samples demonstrated upregulation of the PDGFRβ, VEGFR1, and VEGFR2 genes in UICC stage I-III tumors.” Immunohistological analysis revealed co-expression of PDGF and its putative cross-binding partners, VEGFR2 and EGFR. The team then analyzed several CRC cell lines for PDGFRα, PDGFRβ, VEGFR1, and VEGFR2 protein expression. They found these receptors to be variably expressed amongst the investigated cell lines. Interestingly, whereas Caco-2 and SW480 cells showed expression of all analyzed receptors, HT29 cells expressed only VEGFR1 and VEGFR2. However, stimulation of HT29 cells with PDGF resulted in upregulation of VEGFR1 and VEGFR2 expression despite the absence of PDGFR expression and mimicked the effect of VEGF stimulation. Moreover, PDGF recovered HT29 cell proliferation under simultaneous treatment with a VEGFR or EGFR inhibitor. “Our results provide some of the first evidence for PDGF cross-signaling through alternative receptors in colorectal cancer and support anti-PDGF therapy as a combination strategy alongside VEGF and EGF targeting even in tumors lacking PDGFR expression.” DOI: https://doi.org/10.18632/oncotarget.28281 Correspondence to: Ana Maria Waaga-Gasser - awaaga@bwh.harvard.edu Keywords: PDGF, VEGFR, EGFR, bypassed signaling, colorectal cancer About Oncotarget: Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media: Twitter - https://twitter.com/Oncotarget Facebook - https://www.facebook.com/Oncotarget YouTube – www.youtube.com/c/OncotargetYouTube Instagram - https://www.instagram.com/oncotargetjrnl/ LinkedIn - https://www.linkedin.com/company/oncotarget/ Pinterest - https://www.pinterest.com/oncotarget/ LabTube - https://www.labtube.tv/channel/MTY5OA SoundCloud - https://soundcloud.com/oncotarget For media inquiries, please contact: media@impactjournals.com. Oncotarget Journal Office 6666 East Quaker Str., Suite 1A Orchard Park, NY 14127 Phone: 1-800-922-0957 (option 2)

A new research paper was published in Oncotarget's Volume 13 on October 8, 2022, entitled, “Effectiveness of radiotherapy for local control in T3N0 rectal cancer managed with total mesorectal excision: a meta-analysis.” The total mesorectal excision (TME) significantly improves rectal cancer outcomes. Radiotherapy's benefit in T3N0 rectal cancer patients managed with TME has not been clearly demonstrated. In a new study, researchers Michael Jonathan Kucharczyk, Andrew Bang, Michael C. Tjong, Stefania Papatheodoru, and Jesus C. Fabregas from Nova Scotia Cancer Centre, Dalhousie University, BC Cancer – Vancouver, Princess Margaret Cancer Centre, Harvard T.H. Chan School of Public Health, and University of Florida Health Cancer Center conducted a systematic review and meta-analysis to determine whether radiotherapy alteres the risk of locoregional recurrence (LR) in T3N0 rectal cancer patients managed with a TME. “This systematic review identified unique 7 retrospective cohort studies which evaluated whether radiotherapy reduces LR in T3N0 rectal cancer patients managed with TME.” The studies indexed on PubMed or Embase were systematically searched from inception to October 18, 2020. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were observed for the literature search, study screening and data extraction; the Newcastle Ottawa Scale evaluated bias; Grades of Recommendation, Assessment, Development, and Evaluation Working Group system evaluated certainty. All were performed independently by at least two investigators. Studies that reported LR data specific to T3N0 rectal cancer patients managed with TME, treated with and without radiotherapy, were included. Data was pooled using a random-effects model. Meta-analyses of the relative risk of local recurrence were conducted. Five retrospective cohort studies involving 932 unique patients reported LR outcomes; no prospective studies met eligibility criteria. Median follow-up ranged from 38.4–78 months. Adjuvant radiotherapy was provided in 3 studies. Chemotherapy was delivered and reported in 4 studies, providing both concurrent and adjuvant chemotherapy. A non-significant LR benefit with radiotherapy's addition was estimated. Meta-analysis of exclusively retrospective cohort studies was concerning for biased results. Adequately powered randomized trials are warranted. “With low certainty, this meta-analysis observed a non-significant benefit with radiotherapy to 5-year LR rates among T3N0 rectal cancer patients that received a TME. Until a pragmatically sized randomized control trial is completed, our research adds a layer of data to facilitate informed and personalized treatment decisions for T3N0 rectal cancer patients, albeit with potential significant bias from solely relying on retrospective cohort studies.” DOI: https://doi.org/10.18632/oncotarget.28280 Correspondence to: Michael Jonathan Kucharczyk - michael.kucharczyk@medportal.ca Keywords: radiotherapy, meta-analysis, systematic review, rectal cancer, total mesorectal excision About Oncotarget: Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media: Twitter - https://twitter.com/Oncotarget Facebook - https://www.facebook.com/Oncotarget YouTube – www.youtube.com/c/OncotargetYouTube Instagram - https://www.instagram.com/oncotargetjrnl/ LinkedIn - https://www.linkedin.com/company/oncotarget/ Pinterest - https://www.pinterest.com/oncotarget/ LabTube - https://www.labtube.tv/channel/MTY5OA SoundCloud - https://soundcloud.com/oncotarget For media inquiries, please contact: media@impactjournals.com.

A new research paper was published in Oncotarget's Volume 13 on October 8, 2022, entitled, “In vitro chemotherapy-associated muscle toxicity is attenuated with nutritional support, while treatment efficacy is retained.” Muscle-wasting and treatment-related toxicities negatively impact prognosis of colorectal cancer (CRC) patients. Specific nutritional composition might support skeletal muscle and enhance treatment support. In this new in vitro study, researchers Liza A. Wijler, Francina J. Dijk, Hanil Quirindongo, Danielle A.E. Raats, Bram Dorresteijn, Matthew J.W. Furber, Anne M. May, Onno Kranenburg, and Miriam van Dijk, from University Medical Centre Utrecht, Danone Nutricia Research and Utrecht University, assessed the effect of nutrients eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), L-leucine, and vitamin D3 as single nutrients or in combination on chemotherapy-treated C2C12-myotubes and specific CRC-tumor cells. Using C2C12-myotubes, the effects of chemotherapy (oxaliplatin, 5-fluorouracil, oxaliplatin+5-fluorouracil and irinotecan) on protein synthesis, cell-viability, caspase-3/7-activity and lactic acid dehydrogenase (LDH)-activity were assessed. Addition of EPA, DHA, L-leucine and vitamin D3 and their combination (SNCi) were studied in presence of above chemotherapies. Tumor cell-viability was assessed in oxaliplatin-treated C26 and MC38 CRC cells, and in murine and patient-derived CRC-organoids. While chemotherapy treatment of C2C12-myotubes decreased protein synthesis, cell-viability and increased caspase-3/7 and LDH-activity, SNCi showed improved protein synthesis and cell viability and lowered LDH activity. The nutrient combination SNCi showed a better overall performance compared to the single nutrients. Treatment response of tumor models was not significantly affected by addition of nutrients. “This in vitro study shows protective effect with specific nutrition composition of C2C12-myotubes against chemotherapy toxicity, which is superior to the single nutrients, while treatment response of tumor cells remained.” DOI: https://doi.org/10.18632/oncotarget.28279 Correspondence to: Miriam van Dijk – Email: miriam.vandijk@danone.com Keywords: C2C12 myotubes, chemotherapy, chemotherapy-associated toxicity, colorectal cancer, nutrients, tumor (organoid) cells About Oncotarget: Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media: Twitter – https://twitter.com/Oncotarget Facebook – https://www.facebook.com/Oncotarget YouTube – www.youtube.com/c/OncotargetYouTube Instagram – https://www.instagram.com/oncotargetjrnl/ LinkedIn – https://www.linkedin.com/company/oncotarget/ Pinterest – https://www.pinterest.com/oncotarget/ LabTube – https://www.labtube.tv/channel/MTY5OA SoundCloud – https://soundcloud.com/oncotarget For media inquiries, please contact: media@impactjournals.com

Mickie Kennedy talks with Jason Barnard about how to make press release marketing work for you. Mickie Kennedy is founder and president of eReleases, a leading affordable press release writing and distribution company that has helped more than 10,000 businesses in nearly two decades. eReleases was founded in 1998 with the idea that publicity should not be limited to large companies.  Writing press releases for startups, new product launches or online courses is one way to reach a wider audience through the media and journalists. When crafted with strategic thinking and newsworthiness, press releases can be a very effective marketing approach. But how can you stand out from the crowd and be newsworthy enough to get the attention of the media and journalists?  The groovy Mickie Kennedy and Jason Barnard discuss brilliant tips and tricks around press release marketing for startups: what to think about while writing a press release, why others fail, and the value of press release marketing for companies.Yet another Kalicube Tuesdays episode you should NOT miss

Do you expect a politician to keep their word?  When a candidate says during the primary that they will support the party nominee even if they lose, do you expect them to follow through?  George and callers discuss a Press Release from Colorado lawmaker Ron Hanks who has decided to not support Joe O'Day after pledging to support him during the primary.  See omnystudio.com/listener for privacy information.

A new research paper was published in Oncotarget's Volume 13 on September 28, 2022, entitled, “Genomic alterations predictive of poor clinical outcomes in pan-cancer.” Genomic alterations are highly frequent across cancers, but their prognostic impact is not well characterized in pan-cancer cohorts. In this new study, researchers Crystal S. Seldon, Karthik Meiyappan, Hannah Hoffman, Jimmy A. Guo, Neha Goel, William L. Hwang, Paul L. Nguyen, Brandon A. Mahal, and Mohammed Alshalalfa from the University of Miami, Massachusetts General Hospital, Broad Institute of MIT, University of California San Francisco, and Dana-Farber Cancer Institute and Brigham and Women's Hospital used pan-cancer cohorts from The Cancer Genome Atlas (TCGA) and the MSK-IMPACT study to evaluate the associations of common genomic alterations with poor clinical outcome. “There is growing interest in genomic profiling (i.e. tumor mutations, copy number (CN) alterations) for cancer therapy and precision oncology to inform treatment decisions and identify patients for relevant clinical trials [1].” Full press release - https://www.oncotarget.net/2022/10/04/oncotarget-genomic-alterations-predictive-of-poor-clinical-outcomes-in-pan-cancer/ DOI: https://doi.org/10.18632/oncotarget.28276 Correspondence to: Mohammed Alshalalfa - mohamed.alshalalfa@gmail.com Keywords: genomic alterations, TP53, TCGA, poor prognosis About Oncotarget: Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media: Twitter - https://twitter.com/Oncotarget Facebook - https://www.facebook.com/Oncotarget YouTube – www.youtube.com/c/OncotargetYouTube Instagram - https://www.instagram.com/oncotargetjrnl/ LinkedIn - https://www.linkedin.com/company/oncotarget/ Pinterest - https://www.pinterest.com/oncotarget/ LabTube - https://www.labtube.tv/channel/MTY5OA SoundCloud - https://soundcloud.com/oncotarget For media inquiries, please contact: media@impactjournals.com

In my experience, there are few marketing topics that inspire strong opinions as press releases do. It seems most companies treat them as a given when they make a new hire, release a new product, etc. But ask any marketer whether the bang is really worth the buck and you're bound to get an earful on why press releases don't work. At the same time, there are plenty of examples of companies that have seen great success from press releases. How do they do it? And when should you invest in sending a press release? On this week's episode, eReleases founder Mickie Kennedy shares straight talk on when marketers should - and should not - invest in sending out press releases. He also dives into best practices around how to write a high impact release that will actually get you noticed by the press. Get the details on all of this, and more, in this week's episode. Resources from this episode: Connect with Mickie on LinkedIn Check out the eReleases website Take Mickie's free master class on How to Build a PR Campaign Designed to Get Massive Media Coverage

Press Release publicity can help you launch and grow your small business, with eReleases founder Mickie Kennedy. He shares his tips and advice, based on over 24 years of experience as the founder of eReleases, on how to leverage press releases to get the publicity you need to launch and grow your small business. Mickie founded eReleases to help small businesses, authors, and startups increase their visibility and credibility through press release marketing. Henry Lopez is the host of The How of Business podcast – helping you start, run and grow your small business. The How of Business is a top-rated podcast for small business and entrepreneurs.

Massive Turnout In Wyoming Gameday Vote; More Paramilitary Arrive In Tijuana For The Cartel Wars; Bolduc's Stunning Poll In New Hampshire; The FBI's Weak PRess Release On Child Trafficking; The FBI Steal Trump's Passport: Who Made The Decision